Skip to Main Content

Author Details

Peter Lichter
German Cancer Research Center (DKFZ)
1986
573
123
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37769206Branched-chain amino acid transaminase 1 regulates glioblastoma cell plasticity and contributes to immunosuppression.Neuro Oncol2024
37769206Branched-chain amino acid transaminase 1 regulates glioblastoma cell plasticity and contributes to immunosuppression.Neuro Oncol2024
36658118Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis.Nat Commun2023
35522148Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase KDM4C in B-cell lymphomas.Haematologica2023
36434139The coming decade in precision oncology: six riddles.Nat Rev Cancer2023
37653401scSNPdemux: a sensitive demultiplexing pipeline using single nucleotide polymorphisms for improved pooled single-cell RNA sequencing analysis.BMC Bioinformatics2023
36862549BCAT1 redox function maintains mitotic fidelity.Cell Rep2023
36672428Sphingosine-1-Phosphate Recruits Macrophages and Microglia and Induces a Pro-Tumorigenic Phenotype That Favors Glioma Progression.Cancers (Basel)2023
36844182Simultaneous Inhibition of PI3Kgamma and PI3Kdelta Deteriorates T-cell Function With Implications for Chronic Lymphocytic Leukemia.Hemasphere2023
36658118Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis.Nat Commun2023
37653401scSNPdemux: a sensitive demultiplexing pipeline using single nucleotide polymorphisms for improved pooled single-cell RNA sequencing analysis.BMC Bioinformatics2023
35522148Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase KDM4C in B-cell lymphomas.Haematologica2023
36844182Simultaneous Inhibition of PI3Kgamma and PI3Kdelta Deteriorates T-cell Function With Implications for Chronic Lymphocytic Leukemia.Hemasphere2023
36434139The coming decade in precision oncology: six riddles.Nat Rev Cancer2023
36672428Sphingosine-1-Phosphate Recruits Macrophages and Microglia and Induces a Pro-Tumorigenic Phenotype That Favors Glioma Progression.Cancers (Basel)2023
36862549BCAT1 redox function maintains mitotic fidelity.Cell Rep2023
34417556Longitudinal analyses of CLL in mice identify leukemia-related clonal changes including a Myc gain predicting poor outcome in patients.Leukemia2022
35527719Modeling the B-cell receptor signaling on single cell level reveals a stable network circuit topology between nonmalignant B cells and chronic lymphocytic leukemia cells and between untreated cells and cells treated with kinase inhibitors.Int J Cancer2022
35831316The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors.Nat Commun2022
36083597Exploration of whole genome and transcriptome sequencing data lacks evidence for oncogenic viral elements to drive the pathogenesis of T-cell prolymphocytic leukemia.Leuk Lymphoma2022
36423362COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy.ESMO Open2022
33691380Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapy.Haematologica2022
35013316Association of mutation signature effectuating processes with mutation hotspots in driver genes and non-coding regions.Nat Commun2022
34417556Longitudinal analyses of CLL in mice identify leukemia-related clonal changes including a Myc gain predicting poor outcome in patients.Leukemia2022
35831316The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors.Nat Commun2022
35527719Modeling the B-cell receptor signaling on single cell level reveals a stable network circuit topology between nonmalignant B cells and chronic lymphocytic leukemia cells and between untreated cells and cells treated with kinase inhibitors.Int J Cancer2022
36423362COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy.ESMO Open2022
36083597Exploration of whole genome and transcriptome sequencing data lacks evidence for oncogenic viral elements to drive the pathogenesis of T-cell prolymphocytic leukemia.Leuk Lymphoma2022
33691380Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapy.Haematologica2022
35013316Association of mutation signature effectuating processes with mutation hotspots in driver genes and non-coding regions.Nat Commun2022
32139435Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in Em-TCL1 mice.Haematologica2021
32139435Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in Em-TCL1 mice.Haematologica2021
33953289Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas.Leukemia2021
33526861EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4<sup>+</sup> T cells in chronic lymphocytic leukemia.Leukemia2021
33731935Publisher Correction: LifeTime and improving European healthcare through cell-based interceptive medicine.Nature2021
33450006Evidence for multi-copy Mega-NUMTs in the human genome.Nucleic Acids Res2021
34036222CATCH: A Prospective Precision Oncology Trial in Metastatic Breast Cancer.JCO Precis Oncol2021
32734664A versatile system to introduce clusters of genomic double-strand breaks in large cell populations.Genes Chromosomes Cancer2021
34373263The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets.Cancer Discov2021
34879221Interleukin-10 receptor signaling promotes the maintenance of a PD-1<sup>int</sup> TCF-1<sup>+</sup> CD8<sup>+</sup> T cell population that sustains anti-tumor immunity.Immunity2021
33731935Publisher Correction: LifeTime and improving European healthcare through cell-based interceptive medicine.Nature2021
33526861EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4<sup>+</sup> T cells in chronic lymphocytic leukemia.Leukemia2021
34879221Interleukin-10 receptor signaling promotes the maintenance of a PD-1<sup>int</sup> TCF-1<sup>+</sup> CD8<sup>+</sup> T cell population that sustains anti-tumor immunity.Immunity2021
34036222CATCH: A Prospective Precision Oncology Trial in Metastatic Breast Cancer.JCO Precis Oncol2021
33953289Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas.Leukemia2021
34373263The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets.Cancer Discov2021
33450006Evidence for multi-copy Mega-NUMTs in the human genome.Nucleic Acids Res2021
32734664A versatile system to introduce clusters of genomic double-strand breaks in large cell populations.Genes Chromosomes Cancer2021
31519123CD8<sup>+</sup> T-cells of CLL-bearing mice acquire a transcriptional program of T-cell activation and exhaustion.Leuk Lymphoma2020
32358561DNA methylation of chronic lymphocytic leukemia with differential response to chemotherapy.Sci Data2020
  • 1 - 50 of 1,146

Recommended Authors

Center for Cancer Research, National Cancer Institute
Career Start Year 2005
Number of shared co-authors 2
Beaumont Hospital
Career Start Year 2002
Number of shared co-authors 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 1
Genentech Inc.
Career Start Year 1999
Number of shared co-authors 9
Centene Center for Health Transformation, Centene Corporation
Career Start Year 1998
Number of shared co-authors 18
The First Affiliated Hospital of Guangxi Medical University
Career Start Year 1998
Number of shared co-authors 3
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 9
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 2
Leiden University Medical Center
Career Start Year 1997
Number of shared co-authors 19
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 15
Center for Biomedical Informatics and Information Technology
Career Start Year 1996
Number of shared co-authors 8
Ontario Institute for Cancer Research
Career Start Year 1995
Number of shared co-authors 13
The University of MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 35
Barts Cancer Institute, Queen Mary University of London
Career Start Year 1993
Number of shared co-authors 17
Cancer Center Amsterdam, Vrije Universiteit Amsterdam
Career Start Year 1992
Number of shared co-authors 23
National Human Genome Research Institute
Career Start Year 1990
Number of shared co-authors 12
University of British Columbia
Career Start Year 1988
Number of shared co-authors 16
Cancer Center Amsterdam
Career Start Year 1988
Number of shared co-authors 5
British Columbia Cancer Research Institute
Career Start Year 1987
Number of shared co-authors 18
McGill University
Career Start Year 1986
Number of shared co-authors 56
Institute for Cancer Research, Oslo University Hospital
Career Start Year 1983
Number of shared co-authors 24
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 74
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 9
University of Sao Paulo
Career Start Year 1982
Number of shared co-authors 20
Royal College of Surgeons in Ireland
Career Start Year 1981
Number of shared co-authors 4
Children's Cancer Research Institute, Medical University of Vienna
Career Start Year 1978
Number of shared co-authors 19
Instituto de Salud Carlos III
Career Start Year 1975
Number of shared co-authors 17
Dana-Farber Cancer Institute
Career Start Year 1975
Number of shared co-authors 25
Oregon Health and Science University
Career Start Year 1974
Number of shared co-authors 26
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1970
Number of shared co-authors 42

Collaborators

Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 102
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 84
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 78
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 61
Heinrich Heine University
Co-authored papers 57
Co-authored papers 55
Co-authored papers 54
St Jude Children's Research Hospital
Co-authored papers 48
N.N. Burdenko Neurosurgical Institute
Co-authored papers 39
Co-authored papers 36
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 35
The Hospital for Sick Children
Co-authored papers 35
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 34
Berlin Institute of Health (BIH) and Charite
Co-authored papers 34
Co-authored papers 29
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 28
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 28
Co-authored papers 27
German Cancer Research Center (DKFZ)
Co-authored papers 26
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 25
Co-authored papers 24
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 21
Co-authored papers 20
University Medical Center Hamburg-Eppendorf
Co-authored papers 20
Co-authored papers 19
Mount Sinai Hospital
Co-authored papers 18
Amsterdam University Medical Centers location AMC
Co-authored papers 18
Co-authored papers 18
Charite University Medicine Berlin
Co-authored papers 17
Co-authored papers 17